Neisseria meningitidis

Common Name(s)

Neisseria meningitidis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neisseria meningitidis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neisseria meningitidis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neisseria meningitidis" returned 915 free, full-text research articles on human participants. First 3 results:

Neisseria meningitidis Serogroup C Causing Primary Arthritis in a Child: Case Report.
 

Author(s): Sergiu Straticiuc, Ancuta Ignat, Elena Hanganu, Vasile Valeriu Lupu, Alexandru Bogdan Ciubara, Roxana Cretu

Journal: Medicine (Baltimore). 2016 Feb;95(5):e2745.

 

Neisseria meningitidis (N. meningitidis) is associated with severe invasive infections such as meningitis and fulminant septicemia. Septic arthritis due to N. meningitidis is rare and bone infections have been reported exceptionally. We report the case of a 1-year old girl who presented ...

Last Updated: 5 Feb 2016

Go To URL
Neisseria meningitidis Translation Elongation Factor P and Its Active-Site Arginine Residue Are Essential for Cell Viability.
 

Author(s): Tatsuo Yanagisawa, Hideyuki Takahashi, Takehiro Suzuki, Akiko Masuda, Naoshi Dohmae, Shigeyuki Yokoyama

Journal:

 

Translation elongation factor P (EF-P), a ubiquitous protein over the entire range of bacterial species, rescues ribosomal stalling at consecutive prolines in proteins. In Escherichia coli and Salmonella enterica, the post-translational β-lysyl modification of Lys34 of EF-P is important ...

Last Updated: 4 Feb 2016

Go To URL
HexR Controls Glucose-Responsive Genes and Central Carbon Metabolism in Neisseria meningitidis.
 

Author(s): Ana Antunes, Giacomo Golfieri, Francesca Ferlicca, Marzia M Giuliani, Vincenzo Scarlato, Isabel Delany

Journal:

 

Neisseria meningitidis, an exclusively human pathogen and the leading cause of bacterial meningitis, must adapt to different host niches during human infection. N. meningitidis can utilize a restricted range of carbon sources, including lactate, glucose, and pyruvate, whose concentrations ...

Last Updated: 30 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neisseria meningitidis" returned 25 free, full-text review articles on human participants. First 3 results:

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.
 

Author(s): R Gasparini, D Panatto, N L Bragazzi, P L Lai, A Bechini, M Levi, P Durando, D Amicizia

Journal: J Immunol Res. 2015 ;2015():189153.

 

In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology, immunology, and omics sciences ...

Last Updated: 9 Sep 2015

Go To URL
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
 

Author(s): Gary W Zlotnick, Thomas R Jones, Paul Liberator, Li Hao, Shannon Harris, Lisa K McNeil, Duzhang Zhu, John Perez, Joseph Eiden, Kathrin U Jansen, Annaliesa S Anderson

Journal: Hum Vaccin Immunother. 2015 ;11(1):5-13.

 

Vaccines have had a major impact on the reduction of many diseases globally. Vaccines targeted against invasive meningococcal disease (IMD) due to serogroups A, C, W, and Y are used to prevent these diseases. Until recently no vaccine had been identified that could confer broad protection ...

Last Updated: 10 Feb 2015

Go To URL
Metabolism and virulence in Neisseria meningitidis.
 

Author(s): Christoph Schoen, Laura Kischkies, Johannes Elias, Biju Joseph Ampattu

Journal:

 

A longstanding question in infection biology addresses the genetic basis for invasive behavior in commensal pathogens. A prime example for such a pathogen is Neisseria meningitidis. On the one hand it is a harmless commensal bacterium exquisitely adapted to humans, and on the other ...

Last Updated: 5 Sep 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ciprofloxacin for the Prevention of Meningococcal Meningitis
 

Status: Not yet recruiting

Condition Summary: Meningitis, Meningococcal

 

Last Updated: 25 Mar 2016

Go to URL